Purple Biotech

(NASDAQ) PPBT

Current Price$1.74

Market Cap$2.72M

Since IPO (2015)-100%

5 Year-100%

1 Year-93%

1 Month-44%

Purple Biotech Financials at a Glance

Market Cap

$2.72M

Revenue (TTM)

$0.00

Net Income (TTM)

-$26.17M

EPS (TTM)

-$32.52

P/E Ratio

-0.05

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$1.74

Volume

60,407

Open

$1.67

Price

$1.74

Volume

60,407

Open

$1.67

Previous Close

$1.74

Daily Range

$1.63 - $1.77

52-Week Range

$1.42 - $29.00

Estimated Earnings Date

Aug 5, 2026

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$1.74

Volume

60,407

Open

$1.67

Previous Close

$1.74

Daily Range

$1.63 - $1.77

52-Week Range

$1.42 - $29.00

Estimated Earnings Date

Aug 5, 2026

PPBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Purple Biotech

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Gil Efron, MBA, CPA

Website

www.purple-biotech.com

Headquarters

Rehovot, 7670104, IL

PPBT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-123.47%

Return on Capital

-275.74%

Return on Assets

-178.79%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.72M

Shares Outstanding

1.62M

Volume

60.41K

Avg. Volume

298.94K

Financials (TTM)

Gross Profit

-$53.33K

Operating Income

-$7.84M

EBITDA

-$5.21M

Operating Cash Flow

-$6.80M

Capital Expenditure

-$2.01K

Free Cash Flow

-$6.80M

Cash & ST Invst.

$6.43M

Total Debt

$184.00K

Purple Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.72M

N/A

Market Cap/Employee

$302.60K

N/A

Employees

N/A

Net Income

-$86.00K

+81.0%

EBITDA

$7.00K

+101.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$6.43M

-9.3%

Total Debt

$184.00K

+34.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$184.00K

-32.8%

Return on Assets

-1.79%

N/A

Return on Invested Capital

-3.08%

N/A

Free Cash Flow

-$3.12M

-57.8%

Operating Cash Flow

-$3.12M

-57.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CDTCDT Equity Inc.

CDTCDT Equity Inc.$0.58-8.33%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.04+6.12%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.30+0.78%

XAGELongevity Health Holdings Inc.

XAGELongevity Health Holdings Inc.$0.34+30.38%

MSPRMSP Recovery, Inc.

MSPRMSP Recovery, Inc.$0.01+6.36%

VINCVincerx Pharma, Inc.

VINCVincerx Pharma, Inc.$0.01+0.00%

PBMPsyence Biomedical Ltd.

PBMPsyence Biomedical Ltd.$3.10+4.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92+0.00%

NOKNokia

NOKNokia$13.03+0.00%

TAT&T

TAT&T$21.82-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.17%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.19+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.16-0.08%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.49-0.03%

Questions About PPBT

What is the current price of Purple Biotech?

Purple Biotech is trading at $1.74 per share.

What is the 52-week range for Purple Biotech?

Over the past 52 weeks, Purple Biotech has traded between $1.42 and $29.00.

How much debt does Purple Biotech have?

As of the most recent reporting period, Purple Biotech reported total debt of $184.00K.

How much cash does Purple Biotech have on hand?

Purple Biotech reported $5.57M in cash and cash equivalents in its most recent financial results.

What is Purple Biotech’s dividend yield?

Purple Biotech does not currently have a dividend yield.

Purple Biotech

Purple Biotech Financials at a Glance

PPBT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Purple Biotech

PPBT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Purple Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PPBT

What is the current price of Purple Biotech?

What is the 52-week range for Purple Biotech?

How much debt does Purple Biotech have?

How much cash does Purple Biotech have on hand?

What is Purple Biotech’s dividend yield?

Premium Investing Services